Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

Rocket Lab Delays Neutron Again. Is the Stock in Trouble?fool.com
The company now projects that Neutron's inaugural launch will take place next year.
Via The Motley Fool · October 19, 2026
1 eVTOL Stock That Could Turn $5,000 Into $50,000 -- and the 1 Risk That Could Wipe It Outfool.com
In 2036, Joby Aviation could look like a totally different company.
Via The Motley Fool · October 19, 2026
Micron Technology Stock: Is It a No-Brainer Buy at Less Than $900?fool.com
The stock hasn't been trading this low since early August.
Via The Motley Fool · October 19, 2026
2 "Magnificent Seven" Stocks to Buy and Hold for the Rest of the Decadefool.com
Amazon and Alphabet are my two favorite "Magnificent Seven" stocks to own for the long term.
Via The Motley Fool · October 19, 2026
Why Cleveland-Cliffs Stock Popped Todayfool.com
Cleveland-Cliffs' adjusted EBITDA more than doubles versus Q2 on strong steel pricing.
Via The Motley Fool · October 19, 2026
Illinois Tool Works Faces Headwinds—2 Alternatives Stand Outmarketbeat.com
Illinois Tool Works faces short-cycle demand headwinds and price target cuts, while Watts Water Technologies and the Vanguard Industrials ETF offer alternative ways to play the industrials sector.
Via MarketBeat · October 19, 2026
1 Green Flag and 1 Red Flag for Bloom Energy Investorsfool.com
There's a lot to like about this hydrogen stock, but one factor may charge up investors to look elsewhere.
Via The Motley Fool · October 19, 2026
Is Eli Lilly Stock a Buy Right Now?fool.com
Eli Lilly is growing quickly, lowering realized prices, and building its next wave of drugs. Here's what the numbers say about margins, valuation, and the catalysts that matter next.
Via The Motley Fool · October 19, 2026
Disc Medicine’s Bitopertin Nails Phase III Endpoints, Eyes FDA Resubmissionmarketbeat.com
Disc Medicine (NASDAQ:IRON) said its Phase III APOLLO trial of investigational bitopertin met both co-primary endpoints and all secondary endpoints in patients with erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP), supporting the company’s plan to resubmit a new drug application
Via MarketBeat · October 19, 2026
Dynex Capital Q3 Earnings Call Highlightsmarketbeat.com
Dynex Capital (NYSE:DX) reported a decline in third-quarter book value as higher Treasury yields and wider Agency mortgage-backed securities spreads pressured results, while management said the market repricing has created what it views as an attractive forward investment opportunity. Book value pe
Via MarketBeat · October 19, 2026
CoreWeave Dropped 20% Last Week. Is It Time to Panic or Buy?fool.com
It was a multifaceted perfect storm that hurt CoreWeave's stock.
Via The Motley Fool · October 19, 2026
Why Sandisk Stock Shot Higher Todayfool.com
The chipmaker got a boost from recent developments in the space.
Via The Motley Fool · October 19, 2026
Mortgage Rates Are Rising: The Bank of Canada Hasn’t Movedfool.ca
Fixed mortgage rates can rise without a central-bank move, adding real monthly costs while also testing lenders' funding and credit performance.
Via The Motley Fool · October 19, 2026
A SpaceX-Tesla Merger Could Happen Before the End of 2026. Here's What That Could Mean for the Stocksfool.com
Speculation has been growing that a deal could be on the horizon.
Via The Motley Fool · October 19, 2026
Luxury's Middle Market Is Cracking—These 3 Stocks Could Winmarketbeat.com
LVMH's weak China sales highlight a broader luxury shift toward select brands, positioning Ralph Lauren, Tapestry and Signet Jewelers as stronger U.S.-listed alternatives.
Via MarketBeat · October 19, 2026
Why Intel Stock Popped on Mondayfool.com
JPMorgan just removed its sell rating on Intel stock.
Via The Motley Fool · October 19, 2026
PepsiCo Was Just Dealt Another Blow by Coca-Colafool.com
Fried chicken chain KFC just dropped Pepsi for Coke.
Via The Motley Fool · October 19, 2026
CME vs. Coinbase Global: Which Financial Stock Is a Better Buy in 2026?fool.com
CME trades at a cheaper earnings multiple with fortress-like margins, while Coinbase scales faster but carries regulatory uncertainty.
Via The Motley Fool · October 19, 2026
Semiconductor Sell-Off: 5 Stocks to Buy on the Dipfool.com
These five stocks are worth buying during the current sell-off in the semiconductor space.
Via The Motley Fool · October 19, 2026
Rate-Resilient vs. Rate-Exposed: Why Homebuilder Stocks Are Divergingmarketbeat.com
Rising mortgage rates are splitting homebuilders: Toll Bros' cash-rich luxury buyers keep demand strong, while D.R. Horton sees rising cancellations as first-time buyers get priced out.
Via MarketBeat · October 19, 2026
Opinion: The Most Important Number in Taiwan Semiconductor's Earnings Report Was 68%fool.com
High-performance computing accounted for more than two-thirds of TSMC's quarterly revenue.
Via The Motley Fool · October 19, 2026
Silgan Unveils $3.4B Trivium Deal, Setting Stage for Packaging Giant Spinoffmarketbeat.com
Silgan (NYSE:SLGN) said it has agreed to acquire Trivium Packaging in an all-cash transaction valued at approximately $3.4 billion and plans to combine Trivium with its existing metal containers and food and beverage flat-cap closures operations. The combined metal packaging business, to be called
Via MarketBeat · October 19, 2026
What VinFast Auto (VFS) Said on Its Q2 Earnings Callmarketbeat.com
VinFast Auto (NASDAQ:VFS) reported sharply higher second-quarter vehicle deliveries and revenue as it expanded its electric vehicle lineup and international operations, while losses widened amid deferred revenue, free-charging costs, technology investment and overseas sales incentives. The company
Via MarketBeat · October 19, 2026
Cleveland-Cliffs Q3 Earnings Call Highlightsmarketbeat.com
Cleveland-Cliffs (NYSE:CLF) reported a sharp sequential improvement in third-quarter profitability and said it expects momentum in steel pricing, contract renewals and production utilization to continue into 2027. Chairman and Chief Executive Officer Lourenco Goncalves said third-quarter adjusted E
Via MarketBeat · October 19, 2026
Meta Stock Extends Slide As Big Earnings Test Approachesinvestors.com
Meta stock was lower despite a strong day overall for AI stocks and technology giants. Capex costs will be in focus for Meta's Q3 results.
Via Investor's Business Daily · October 19, 2026